# Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients

> **NCT02039557** · — · COMPLETED · sponsor: **Gamida Cell ltd** · enrollment: 33 (actual)

## Conditions studied

- Patients Transplanted With NiCord/CordIn (Omidubicel)

## Interventions

- **GENETIC:** NiCord®/CordIn™ (omidubicel)

## Key facts

- **NCT ID:** NCT02039557
- **Lead sponsor:** Gamida Cell ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05-01
- **Primary completion:** 2023-06-29
- **Final completion:** 2023-06-29
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2024-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02039557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02039557, "Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02039557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*